MMWR Morb Mortal Wkly Rep. 2002 May 10;51(18):392-4.
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia, otitis media, and meningitis in the United States. Antimicrobial susceptibility results are important for guiding therapy decisions and monitoring emerging resistance patterns. Appropriate methods for pneumococcal susceptibility testing are recommended by the National Committee for Clinical Laboratory Standards (NCCLS). Recommendations for pneumococcal susceptibility testing are reviewed annually and were the same in 2000 and 2001. To assess laboratory practices for Streptococcus pneumoniae susceptibility testing on sterile site isolates, in February 2000, CDC conducted a multistate survey of clinical laboratories. This report summarizes the survey results, which found that most practices of clinical laboratories were consistent with NCCLS recommendations; however, some inconsistencies were noted. As antimicrobial resistance in pneumococci continues to worsen, clinical laboratories should be aware of emerging resistance patterns and follow new recommendations to provide clinicians with precise information about antimicrobial susceptibility.
肺炎链球菌是美国社区获得性肺炎、中耳炎和脑膜炎的主要病因。抗菌药物敏感性结果对于指导治疗决策和监测新出现的耐药模式很重要。美国国家临床实验室标准委员会(NCCLS)推荐了用于肺炎球菌敏感性测试的适当方法。肺炎球菌敏感性测试的建议每年都会进行审查,2000年和2001年的建议相同。为了评估临床实验室对无菌部位分离株进行肺炎链球菌敏感性测试的操作情况,2000年2月,美国疾病控制与预防中心(CDC)对临床实验室进行了一项多州调查。本报告总结了调查结果,结果发现临床实验室的大多数操作与NCCLS的建议一致;然而,也发现了一些不一致之处。随着肺炎球菌的抗菌耐药性持续恶化,临床实验室应了解新出现的耐药模式,并遵循新的建议,以便为临床医生提供有关抗菌药物敏感性的准确信息。